# LRFN5 and OLFM4 in Bipolar Disorder

> **NCT07434414** · — · COMPLETED · sponsor: **Elazığ Mental Health and Diseases Hospital** · enrollment: 72 (actual)

## Conditions studied

- Bipolar Disorder (BD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07434414
- **Lead sponsor:** Elazığ Mental Health and Diseases Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-07
- **Primary completion:** 2026-01-02
- **Final completion:** 2026-01-02
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07434414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07434414, "LRFN5 and OLFM4 in Bipolar Disorder". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07434414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*